GB
Geetanjali Bhanudas Bendale
About Geetanjali Bhanudas Bendale
Data last updated:
Geetanjali Bhanudas Bendale is a Director at Pharchem Private Limited (since 2020). The company operates in Pharma. Pharchem Private Limited reported revenue of ₹20.20 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Mar 2020 | 2020 | ₹20.20 Cr (FY 2024) | Active |
Board colleagues of Geetanjali Bhanudas Bendale
| Name | DIN | Company | Designation |
|---|---|---|---|
| Milind Balwant Save | 00707180 | Pharchem Private Limited | Director |
| Nimish Manohar Patil | 09591701 | Pharchem Private Limited | Director |
| Swarali Milind Save | 05221699 | Pharchem Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Geetanjali Bhanudas Bendale
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Geetanjali Bhanudas Bendale
Geetanjali Bhanudas Bendale currently holds 1 directorship: Pharchem Private Limited (Director, since 16 Mar 2020, revenue ₹20.20 Cr (FY 2024)).
Geetanjali Bhanudas Bendale was first appointed on 16 Mar 2020 as Director at Pharchem Private Limited.
The current boards of Geetanjali Bhanudas Bendale's companies include Milind Balwant Save (Pharchem Private Limited), Nimish Manohar Patil (Pharchem Private Limited), Swarali Milind Save (Pharchem Private Limited).